5006-20-2Relevant articles and documents
Evaluation of 2-methyl-3-hydroxy-4-pyridinecarboxylic acid as a possible chelating agent for iron and aluminium
Dean, Annalisa,Ferlin, Maria Grazia,Brun, Paola,Castagliuolo, Ignazio,Badocco, Denis,Pastore, Paolo,Venzo, Alfonso,Bombi, G. Giorgio,Di Marco, Valerio B.
, p. 1689 - 1697 (2008)
In view of a possible application to Fe and Al chelation therapy, 2-methyl-3-hydroxy-4-pyridinecarboxylic acid (DT2) was synthesised, and its complex formation, electrochemical and cytotoxic properties were studied. The complexing properties of DT2 towards Fe(iii) and Al(iii) were investigated in aqueous 0.6 m (Na)Cl at 25 °C by means of potentiometric titrations, UV-vis spectrophotometry, and 1H NMR spectroscopy. DT2 is a triprotic acid (H3L+) having pKa1 = 0.47, pKa2 = 5.64 and pKa3 = 11.18. The metal-ligand complexes observed in solution and their corresponding stability constants (logβ values) are the following: FeLH (19.38), FeL (16.01), FeLH-1 (12.28), FeL 2H2 (37.29), FeL3H3 (53.41), FeL3H2 (47.99), FeL3H (41.21) and FeL 3 (34.1); AlLH (17.43), AlL2H2 (33.74), AlL2H (27.6), AlL3H3 (48.72), AlL 3H2 (42.67), AlL3H (35.8) and AlL3 (27.92). The complex formation between DT2 and Fe(ii) was studied by UV-vis: the weak complex FeLH (logβ = 15.8) was detected. DT2 shows a lower complexation efficiency with Fe(iii) and Al(iii) than that of other available chelators, but higher than that of its non-methylated analogue 3-hydroxy-4-pyridinecarboxylic acid (DT0). The electrochemical behaviour of DT2 was investigated by means of cyclic voltammetry, indicating that the oxidation of the ligand proceeds through a two electron process with a CECE mechanism. Voltammetric curves suggest that the oxidation or the reduction of DT2 in vivo is unlikely. According to the thermodynamic data, also the Fe(iii)-DT2 complexes do not undergo redox cycling at physiological pH. Amperometric titrations of solutions containing Fe(iii) and DT2 at pH = 5 indicated the same Fe(iii): ligand stoichiometric ratio as calculated from potentiometric data. The toxicity of DT2 and of other simple hydroxypyridinecarboxylic acids was investigated in vitro and no cytotoxic activity was observed (IC50 > 0.1 mM) on cancer cell lines and also on primary human cells, following a three day exposure. The Royal Society of Chemistry.
Preparation method of 4-methyl-5-ethoxy oxazole
-
Paragraph 0005; 0016-0039, (2021/04/26)
The invention discloses a preparation method of 4-methyl-5-ethoxy oxazole, which comprises the following steps of by using N-formyl alanine ethyl ester as a raw material, directly cyclizing in the presence of boron trifluoride diethyl etherate and metal oxide to obtain 4-methyl-5-ethoxy oxazole, which has a reaction general formula (1). The preparation method of the novel 4-methyl-5-ethoxy oxazole is short in route, simple to operate, high in conversion rate and good in atom economy, the used materials such as boron trifluoride diethyl ether can be recycled and reused, a large amount of wastewater cannot be generated, and the preparation method is very suitable for industrial production.
Preparation method of 4-alkyl-5-alkoxy oxazole compound
-
Paragraph 0040-0041, (2020/02/14)
The invention discloses a preparation method of a 4-alkyl-5-alkoxy oxazole compound. The preparation method comprises the following steps: under the action of a catalyst, carrying out transesterification on 4-alkyl-5-alkoxy oxazole-2-carboxylic ester and acid in a solvent to obtain an oxazole acid intermediate, and carrying out decarboxylation reaction on the oxazole acid intermediate to obtain the 4-alkyl-5-alkoxy oxazole compound. The preparation method has the advantages of no wastewater generation in the reaction process, cheap and accessible catalyst and high reaction yield, and is convenient for industrial production.